Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Persistent Globus Sensation
NCT05432843Phase 4Unknown
- Sponsor
- UZ Leuven
- Start
- Mar 2010
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in globus sensation comparing Pregabalin with Placebo (2 arms). Primary endpoint: Clinical remission at 8 weeks. Status: unknown.
02
Drugs
pregabalin
03
Conditions
globus sensation
Beyond the preview
Go deeper on NCT05432843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05432843.